JF
CBAY

Jump Financial’s Cymabay Therapeutics CBAY Stock Holding History

Jump Financial’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-63,684
Closed -$950K – 2376
2023
Q3 		$950K Buy
+63,684
New +$844K 0.04% 694
2023
Q1 		– Sell
-70,801
Closed -$444K – 2154
2022
Q4 		$444K Buy
+70,801
New +$269K 0.02% 834
2021
Q2 		– Sell
-40,700
Closed -$185K – 1461
2021
Q1 		$185K Sell
40,700
-19,990
-33% -$108K 0.02% 771
2020
Q4 		$348K Buy
+60,690
New +$459K 0.06% 537

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return